Abstract BACKGROUND: The effects of the BRAF V600E mutation on prognostic factors and poor clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The authors performed comprehensive meta‐analysis to assess the strength of associations between these conditions and the BRA...
No comments yet
Be the first to share your thoughts!